CDC awaits permanent director as acting leadership continues
The Trump administration has postponed the nomination of a new director for the US Centers for Disease Control and Prevention (CDC), with the White House yet to finalize its selection, reports BritPanorama.
Dr. Jay Bhattacharya, who also heads the US National Institutes of Health, will maintain oversight of the CDC by performing the delegable duties of the CDC director, according to a statement from Andrew Nixon, a spokesperson for the Department of Health and Human Services (HHS). Despite currently being in the role of acting director, this may change soon, as HHS seeks to nominate a permanent successor.
An HHS official informed that new candidates for the CDC directorship are being evaluated alongside previous contenders. The urgency of the situation is underscored by the federal Vacancies Act, which limits acting officials’ tenure to 210 days. This Thursday marks 210 days since Dr. Susan Monarez was dismissed from the position by HHS Secretary Robert F. Kennedy Jr.
During an all-hands meeting at the CDC on Wednesday, Bhattacharya expressed optimism that a permanent director would be named soon. If no selection is made by that time, he stated that he does not expect much to change within the organization. HHS officials have indicated confidence that Bhattacharya’s continued role, sans the official title, is legally sound and will withstand scrutiny.
Nixon further elaborated that Secretary Kennedy and Chris Klomp, recently appointed chief counselor of HHS, are working on the search for a new CDC director, aiming to align with the administration’s vision of returning the CDC to its core mission of combating infectious diseases.
In congressional testimony last fall, Monarez revealed she was dismissed after only 29 days due to her refusal to endorse changes to vaccine policy proposed by the administration. She was the second appointee to lead the agency after the White House initially withdrew the nomination of Dr. Dave Weldon, a former congressman from Florida, due to insufficient support for confirmation.
The CDC has faced a tumultuous period, marked by a shooting incident at its Atlanta headquarters shortly after Monarez’s appointment, where a gunman fired over 180 rounds, resulting in the death of a police officer. Bullet holes in the campus remain as a haunting reminder of ongoing challenges.
Compounding these issues, significant staffing cuts have taken place, weakening various divisions within the agency, although some positions have been reinstated following legal actions. There have also been reports of political interference in the agency’s public messaging around vaccine safety, raising concerns about the integrity of the CDC’s recommendations.
Kennedy’s decision to replace a key advisory panel on vaccines with his handpicked experts has prompted criticism, particularly given that many of the new appointees have been reported to undermine established understandings of vaccine safety. Polls indicate that trust in US health agencies has significantly declined during his tenure.
Infectious disease experts warn that the US is experiencing its highest rates of measles infection in three decades, posing risks to public health that may undermine the country’s previous success in controlling such diseases. Other illnesses, including whooping cough and mumps, are similarly on the rise as vaccination rates drop, amplifying fears that neglect in leadership could lead to serious repercussions.
Public health advocates voiced concern regarding the delay in appointing a permanent CDC director, emphasizing a lack of urgency from both the Trump administration and Kennedy. Kayla Hancock, director of the Public Health Project with Protect Our Care, criticized this inaction as emblematic of incompetence and neglect in safeguarding American public health.
As the search for new leadership unfolds, the ongoing challenges within the CDC highlight the complexities faced by health agencies under current political dynamics, raising questions about the future direction of public health responses in the United States.
